Elizabeth Weesner, Hosain Ghassemi, Iryna Salapenka, Jaya Sri Konakanchi, Gregory Maggio, Sethi R. Injection Site Reaction to Extended-Release Buprenorphine (Sublocade®) for Opioid Use Disorder Fourteen Days after Administration. kjm [Internet]. 2022 Aug. 22 [cited 2024 May 7];15(2):302-4. Available from: https://journals.ku.edu/kjm/article/view/17931